The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic

The emergence and global impact of COVID-19 has focused the scientific and medical community on the pivotal influential role of respiratory viruses as causes of severe pneumonia, on the understanding of the underlying pathomechanisms, and on potential treatment for COVID-19. The latter concentrates...

Full description

Bibliographic Details
Main Authors: Ludwig Aigner, Frank Pietrantonio, Diana Marisa Bessa de Sousa, Johanna Michael, Daniela Schuster, Herbert Anton Reitsamer, Horst Zerbe, Michael Studnicka
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Molecular Biosciences
Subjects:
leukotrienes
leukotriene receptor antagonist (LTRA)
viral pneumonia
COVID-19
inflammation
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2020.610132/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2020.610132/full

Similar Items